Blunt Roy sold $158K of THC
Blunt Roy sold 600 shares of TENET HEALTHCARE CORP (THC) at $262.68 ($0.16M total) on 2026-08-05.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider activity record for Tenet Healthcare but does not include any operational, financial, or regulatory development.
Market read
Traders may note insider selling as a sentiment datapoint, but there is no new fundamental catalyst in the text.
What to watch
The article does not state whether the sale was part of a 10b5-1 plan (it says no), nor does it provide context on total holdings, prior sales cadence, or whether other insiders sold/bought around the same time.
Background
The filing is an SEC Form 4 insider transaction by a Tenet Healthcare director, reporting an open-market sale of shares.
Ticker impact
Tenet Healthcare director Blunt Roy filed a Form 4 selling 600 shares at $262.68 on 2026-08-05, totaling about $157.6K.
Likely limited near-term impact; any effect would be sentiment-driven and small.
Form 4 insider sales are common and often pre-planned; the filing provides transaction size and price but no accompanying company-specific news or guidance change.
Market effects
No sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
The sale may be for diversification, taxes, or liquidity needs and may not reflect bearish expectations, especially without any other negative company news.
Key entities
- issuerTenet Healthcare Corp
Subject of the Form 4 insider sale disclosure.
- insiderBlunt Roy
Director who sold 600 shares in an open-market transaction.
